Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

NCT02346240 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

559

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis
Plaque Psoriasis

Interventions

BIOLOGICAL: Certolizumab Pegol
BIOLOGICAL: Etanercept
OTHER: Placebo

Sponsor

UCB Biopharma S.P.R.L.